Full Press Release Details
FINAL REMINDER FOR BIOSCRIP 2013 INVESTOR
RSVP REQUESTED TO ATTEND
Elmsford, NY - September 23, 2013
- BioScrip , Inc. (NASDAQ: BIOS) today issued a final
reminder regarding its previously announced inaugural Investor Day to be held Tuesday, September 24, 2013, at Le Parker Meridien
located at 119 West 56th Street in New York City. At the meeting, BioScrip will address the Company's expected performance and
outlook for the remainder of 2013.
Institutional investors and analysts who
have not already registered and who are still interested in attending are requested to rsvp to attend the Investor Day by responding
to Lisa Wilson in BioScrip's Investor Relations department either via telephone at 212-759-3929 or e-mail at: lwilson@insitecony.com.
The meeting will also be available concurrently
via a live audio webcast on BioScrip's website at www.bioscrip.com, under the Investors section. Investors who are unable
to attend in person may submit questions for the question-and-answer segment via e-mail to: lwilson@insitecony.com.
A webcast replay will be available for
on-demand listening shortly after the completion of the event until 11:59 p.m. Eastern Time on Tuesday, October 8, 2013, at www.bioscrip.com,
under the Investors section.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider
of infusion and home care solutions. BioScrip partners with physicians, healthcare payors, government agencies, hospital systems
and pharmaceutical manufacturers to provide patients access to post-acute care services. BioScrip operates with a commitment to
bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating
with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by quality,
customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves. BioScrip provides
its infusion and home care services from 108 locations across 29 states.
Investor Relations for BioScrip, Inc.